Optomed Oyj, a medical technology company, provides handheld fundus cameras and eye-screening devices in Finland, China, and internationally. The company operates through two segments, Devices and Software segments. It offers handheld fundus camera products, which are used in ophthalmology, pediatric care, endocrinology, neurology, and primary care. Its product portfolio consists of Optomed Smartscope Pro, Optomed Aurora, and Optomed Aava, as well as OEM cameras, including Pictor Plus, Pictor Prestige, Visuscout 100, Fundus Module 300, and Signal; and desktops cameras, such as Optomed Polaris tabletop fundus cameras and Optomed Halo portable retinal cameras. The company also provides Optomed Avenue, a Software-as-a-Service (SaaS) platform that offers access to artificial intelligence services, screening process management tools, and remote image analyses; Avenue Eye Screen, a workflow management system for screening and monitoring of eye diseases, such as diabetic retinopathy; Avenue Telemedicine, a remote analysis solution for faster access to medical consultation; Avenue Viewer, a patient data management solution for viewing, reporting, and archiving fundus images; and Avenue Sync, a software solution. In addition, it offers process management software for various cancer screenings; radiology information system, a software system for healthcare imaging units for managing medical images and associated data; and solution for digital pathology. Further, the company provides professional IT consulting services for government institutions. It sells its products and solutions through OEMs, distributors, and direct sales. The company’s customers include hospitals, eye clinics, and optician chains and stores. The company was founded in 2004 and is headquartered in Oulu, Finland.